Bolt Biotherapeutics
BOLT
BOLT
71 hedge funds and large institutions have $449M invested in Bolt Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $514M → $449M (-$64.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
71
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$10.5M | |
| 2 | +$7.24M | |
| 3 | +$5.25M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.89M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.91M |
Top Sellers
| 1 | -$2.32M | |
| 2 | -$2.19M | |
| 3 | -$1.98M | |
| 4 |
Morgan Stanley
New York
|
-$1.33M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.14M |